Skip to main content
TELCON RF PHARMACEUTICAL. Inc. logo

TELCON RF PHARMACEUTICAL. Inc. — Investor Relations & Filings

Ticker · 200230 ISIN · KR7200230001 KO Manufacturing
Filings indexed 351 across all filing types
Latest filing 2023-12-15 Regulatory Filings
Country KR South Korea
Listing KO 200230

About TELCON RF PHARMACEUTICAL. Inc.

http://www.telcon-rf.com

TELCON RF PHARMACEUTICAL. Inc. operates across two primary business segments: radio frequency (RF) components and pharmaceuticals. The RF division specializes in the development, manufacturing, and global sale of components for wireless communication equipment. Its main products include RF coaxial connectors, cable assemblies, coaxial couplers, and distributors. The pharmaceutical and biotechnology division is engaged in the development and sale of medicinal products.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement from Telcon RF Pharmaceutical regarding the setting of a record date for the purpose of holding an Annual General Meeting (AGM). It specifies the record date (2023-12-31) and the reason (holding the 25th AGM). Since this is a regulatory notification regarding meeting logistics rather than the meeting materials themselves or a full report, it falls under the general regulatory filing category.
2023-12-15 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (Telcon RF Pharmaceutical) regarding the exercise of conversion rights for convertible bonds (전환청구권 행사). This type of filing details the issuance of new shares resulting from the conversion of debt into equity, which directly impacts the company's capital structure and share count. According to the provided definitions, this falls under 'Share Issue/Capital Change' (SHA).
2023-12-06 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (Telcon RF Pharmaceutical) regarding the exercise of conversion rights for convertible bonds. This type of filing, which details changes in capital structure due to the conversion of debt into equity, falls under the category of 'Share Issue/Capital Change' as it directly impacts the number of outstanding shares and the company's capital structure.
2023-12-05 Korean
분기보고서 (2023.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Telcon RF Pharmaceutical' (텔콘알에프제약) covering the period from January 1, 2023, to September 30, 2023. It contains detailed financial statements, management discussion, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-11-14 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory announcement regarding the adjustment of the conversion price for convertible bonds (전환가액의 조정) issued by Telcon RF Pharmaceutical. It details the specific changes to the conversion price, the number of convertible shares, and the underlying reasons (market price decline). This type of filing is a standard corporate disclosure regarding capital structure changes and financing instruments, which falls under the 'Capital/Financing Update' category.
2023-10-31 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal notification regarding the adjustment of the conversion price for convertible bonds (CB) issued by Telcon RF Pharmaceutical. It details the change in conversion price due to a decline in market price, the resulting change in the number of convertible shares, and the calculation methodology. This type of filing is a standard regulatory disclosure in the Korean market (KOSDAQ/KRX) concerning capital structure and financing instruments, which falls under the 'Capital/Financing Update' category.
2023-10-04 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.